Dear valued user,
Thank you for using Clearpol. Your support has been invaluable to us and we truly appreciate it. We launched Clearpol two years ago and thousands of users like you have joined us in our mission to simplify healthcare compliance. During the pandemic, we put Clearpol out for free as our way of helping, so you could focus on taking care of your residents.
Listen to our origin story here
As we move forward, we are determined to empower you with cutting-edge AI-enabled tools that will make managing compliance effortless. To bring this vision to life we've partnered with UC Berkeley, a leader in public health and AI research. We will also launch a PRO subscription starting March 1st to ensure the sustainability of Clearpol and to continuously improve the platform for all users. After March 1st, many existing, new, and future features will require a PRO subscription.
As a token of appreciation, we will be offering early adopters, students, and other special users the opportunity to be grandfathered in at an incredibly steep discount. Look out for future communications if you fall into that category.
Thank you for your understanding and continued support. We look forward to serving you in the future.
Best regards,
The Clearpol Team
The Comparison for this document will be available soon.
Your account is being upgraded to Pro!
Signup for Clearpol Pro to benefit from the following premium features and more...
$55/month
$45/month
Try Free for 2 Weeks$350/month
$250/month
Try Free for 2 WeeksWe're sorry to hear that! Help us improve our service, please take a moment to tell us why.
Signup for Clearpol Pro to benefit from the following premium features and more...
$55/month
$45/month
Try Free for 2 Weeks$350/month
$250/month
Try Free for 2 WeeksWe're sorry to hear that! Help us improve our service, please take a moment to tell us why.
Signup for Clearpol Pro to benefit from the following premium features and more...
$55/month
$45/month
Try Free for 2 Weeks$350/month
$250/month
Try Free for 2 WeeksWe're sorry to hear that! Help us improve our service, please take a moment to tell us why.
Signup for Clearpol Pro to benefit from the following premium features and more...
$55/month
$45/month
Try Free for 2 Weeks$350/month
$250/month
Try Free for 2 WeeksWe're sorry to hear that! Help us improve our service, please take a moment to tell us why.
The information provided is used to show regulations that are relevant to your region/facility. By using the platform you agree to the terms and conditions.
Clearpol Inc. does not make any guarantees regarding the accuracy of the opinions provided on our platform. Please use your own judgement.
The California Department of Health has issued a new All Facilities Letter regarding the use of Interferon Gamma Release Assay (IGRA) blood tests for identifying Mycobacterium Tuberculosis infection in healthcare workers. The letter states that the use of IGRA blood tests requires a grant of program flexibility from the California Department of Public Health's Licensing and Certification Program, as the Tuberculin Skin Test (TST) is required by regulation. Facilities must submit a letter to the Licensing and Certification district office requesting program flexibility for the use of IGRA blood tests. They must also submit a policy specifying the IGRA blood test to be used in screening healthcare workers for Latent Tuberculosis Infection (LTBI), complying with current standards of practice for LTBI screening as defined by the California Occupational Safety and Health Administration. The policy must specify the group of employees in which the IGRA will be used and include a statement that employees will be informed in writing of the limitations of using IGRAs as defined by the most current recommendations by the CDC or the California Tuberculosis Controllers Association.
Clearpol Inc. does not make any guarantees regarding the accuracy of the opinions or summaries provided on our platform. Please use your own judgement.
| Task | Deadline | Actions |
|---|
Click below to print the document in a new window. When finished, you can return to this tab to continue.
Print PDF
Copy Document Link
Please enter a Name.
Please enter a valid email address.
Please enter a first name.
Please enter a last name.
Please enter a valid email address.
